Houston Chronicle

(PRN) DelSite Biotechnologies Announces Agreement with Invitrogen Corporation for Process ...

Cell-Based Flu Antigen to Be Incorporated in DelSite's Nasal Vaccine Product IRVING, Texas and CARLSBAD, Calif., March 1 /PRNewswire-FirstCall/ -- DelSite ...